Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys.
about
MDMA and the “Ecstasy Paradigm”Nonhuman primate positron emission tomography neuroimaging in drug abuse researchNeuroimaging and drug taking in primatesThe effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studiesNeuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.Ecstasy: are animal data consistent between species and can they translate to humans?Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction.The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse.Endocrine and neurochemical effects of 3,4-methylenedioxymethamphetamine and its stereoisomers in rhesus monkeys.MDMA effects consistent across laboratories.The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens.Human Ecstasy use is associated with increased cortical excitability: an fMRI study.Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines.Differential effects of cocaine and MDMA self-administration on cortical serotonin transporter availability in monkeys.MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI studyRole of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates.N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study.Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.Occipital cortical proton MRS at 4 Tesla in human moderate MDMA polydrug usersEffects of cocaine and MDMA self-administration on serotonin transporter availability in monkeys.Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges.Novel technology for modulating locomotor activity as an operant response in the mouse: implications for neuroscience studies involving "exercise" in rodents.Effects of the selective sigma receptor ligand, 1-(2-phenethyl)piperidine oxalate (AC927), on the behavioral and toxic effects of cocaineNeuroimaging in human MDMA (Ecstasy) users.The Reinforcing and Rewarding Effects of Methylone, a Synthetic Cathinone Commonly Found in "Bath Salts"Further studies on the role of metabolites in (+/-)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity.Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration.Drugs as instruments: a new framework for non-addictive psychoactive drug use.Contribution of Impulsivity and Serotonin Receptor Neuroadaptations to the Development of an MDMA ('Ecstasy') Substance Use Disorder.The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy.Column chromatography analysis of brain tissue: an advanced laboratory exercise for neuroscience majors.Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis.Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users.Long-term voluntary consumption of MDMA and THC in rats is modified by individual and situational factors.MDMA and the loss of reinforcement in Fantegrossi et al (2004).High ambient temperature facilitates the acquisition of 3,4-methylenedioxymethamphetamine (MDMA) self-administration.Rewarding effects and reinstatement of MDMA-induced CPP in adolescent mice.Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphetamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine.Self-administered MDMA produces dose- and time-dependent serotonin deficits in the rat brain.Rats preexposed to MDMA display attenuated responses to its aversive effects in the absence of persistent monoamine depletions.
P2860
Q21558618-A497F271-6AA2-408A-BF49-F512E720E7E7Q24607038-4C30A785-480E-4512-ACC8-A6E7265B31E5Q24631230-72884C76-7AD6-43C3-B99C-D027F29D4E21Q28069364-D10AB734-D50F-4EC1-A132-E93BA27CC26CQ31033312-E4023042-E3D5-4C4F-A137-9F781FCF060AQ31033315-5AA22692-ED09-46B0-A842-5259F6E800FEQ33383360-B3A0ECCB-009C-4D4E-99F2-F05E725FBAD0Q33886313-3E1CEBD1-105C-4538-A2CE-7F751BBF9609Q34035262-3D74613F-A137-4A2C-A80E-92D88A51DD6DQ34167689-C7FD2C45-4CE8-41E1-A89D-33C9DB166EA0Q34546304-F37A6E03-4017-44EC-887E-7FB9C454B57DQ34820201-9861A7D2-FE47-4203-865E-A49CFE20004AQ35010538-CE883792-0D87-4B08-93AB-8F0DD1226F60Q35017128-FE54DA5F-B240-4516-B58B-015BC84FFFC5Q35415158-F5FA6A2A-503D-414E-A97A-C35B7C39C0B8Q35590703-F6880D9D-1D4A-471D-AE3B-8F4BF95776F1Q35671537-05F3E896-8C4D-478E-B110-8CB631906D47Q36020276-4D356F70-60D2-44F2-90BD-0C7A3903FEE5Q36255067-3ED32854-B79C-43A3-BB24-4D54DF3CDB83Q36312733-BFFB570A-DCE2-44AD-965D-17EE4A2DEB1DQ36666580-8ADD300B-8CD7-4D63-A03B-265925F83EE3Q36776203-A40E256C-1D61-4812-9D1B-2E6B3282F6A2Q36870910-90C6CC3C-C096-4F34-A77D-0DD3095000ECQ37181415-9CF215FF-1EB1-4418-994B-FA24131B99DDQ37310323-0B9EE578-692E-44C7-994A-9917E7782A1EQ37402744-1E54FB35-9557-4ED1-85AA-6838175B7417Q39026719-DB92A276-1150-44E8-AF65-27EE50178CDDQ39688095-6E49E55B-22A1-4CB9-A5B6-AF1EA14F712EQ40157269-4114156A-33A2-4420-8185-A4E5EE75AB1FQ40359394-E5FC4E5A-3B01-413C-B39E-D918E360E52AQ41415909-F09703CD-D9A0-4AFB-A93A-6EB1BF5817E3Q44252300-A2EACD7B-51D7-4B92-B7A4-DA84958B4E34Q44255973-1E20D0B6-C7F9-4C8B-ACD7-720E14D3F2FDQ45031827-730E84E2-FFC9-4C09-AADF-41C6096E4945Q45071437-84C8E609-336F-484E-A8EC-F83356E30F7DQ47312691-2EDAA92D-E41E-4B8C-942D-3FF707E0D417Q48273339-1FCCBC10-1E93-454C-A13F-154EE6DE6AB9Q48398184-463B881F-7A14-4CF4-80F7-4C6779F0841DQ48874172-902CD427-C0F5-485E-A207-F73022D0DCDEQ51887349-A4E222FB-A5D0-4FC3-AA03-FC4D05BA5397
P2860
Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Behavioral and neurochemical c ...... enantiomers by rhesus monkeys.
@en
Behavioral and neurochemical c ...... enantiomers by rhesus monkeys.
@nl
type
label
Behavioral and neurochemical c ...... enantiomers by rhesus monkeys.
@en
Behavioral and neurochemical c ...... enantiomers by rhesus monkeys.
@nl
prefLabel
Behavioral and neurochemical c ...... enantiomers by rhesus monkeys.
@en
Behavioral and neurochemical c ...... enantiomers by rhesus monkeys.
@nl
P2093
P2860
P356
P1476
Behavioral and neurochemical c ...... enantiomers by rhesus monkeys.
@en
P2093
Gail Winger
George A Ricaurte
George Hatzidimitriou
James H Woods
Michael Kilbourn
Phillip Sherman
William E Fantegrossi
William L Woolverton
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300442
P407
P577
2004-07-01T00:00:00Z